The global cerebrospinal fluid (CSF) management market is expected to reach USD 1.56 Billion by 2022 from USD 1.26 Billion in 2017, at a CAGR of 4.4%. The global cerebrospinal fluid (CSF) management ...

Direct Translation of a Protracted Irinotecan Schedule From a Xenograft Model to a Phase I Trial in Children PURPOSE: Leptomeningeal disease (LMD) significantly affects the prognosis and treatment of ...

The US Food and Drug Administration (FDA) is warning healthcare providers about potential hazards from interactions between implanted programmable cerebrospinal fluid (CSF) shunts and hearing implants ...

Custom Safety Update image Individuals with an implantable programmable cerebrospinal fluid shunt are at risk for unintended changes to valve settings through exposure to magnetic fields present in ...